TRVN

Trevena, Inc. [TRVN] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

TRVN Stock Summary

Top 10 Correlated ETFs

TRVN


Top 10 Correlated Stocks

TRVN


In the News

09:10 28 Mar 2024 TRVN

Go Beyond Bargain Hunting; Buy 5 Stocks With Rising P/E

Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include OpGen (OPGN), The RealReal (REAL), Trevena (TRVN), ChargePoint (CHPT) and Caterpillar (CAT).

11:16 28 Mar 2024 TRVN

5 Hot Penny Stocks To Watch With Big News This Week

Whether you're trading penny stocks or higher-priced company shares, everyone wants to gain an edge. In the stock market today, there are plenty of catalysts to consider.

09:38 28 Mar 2024 TRVN

‘It's ridiculous.' Buy short-term Treasury bills because debt-ceiling deal will come, says bond legend Bill Gross

Friday's bullish session on Wall Street seems to have gone nowhere, save for the Nasdaq Composite COMP wriggling its way out of a bear market.

07:00 28 Mar 2024 TRVN

Trevena to Release First Quarter 2023 Financial Results on May 15, 2023

CHESTERBROOK, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that it will release its financial results for the first quarter ended March 31, 2023, prior to the market open on Monday, May 15, 2023.

06:34 28 Mar 2024 TRVN

Momentum Trading With Penny Stocks: Quick Guide

Use these tips to make money when momentum trading penny stocks The post Momentum Trading With Penny Stocks: Quick Guide  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

01:31 28 Mar 2024 TRVN

Trevena stock soars toward 5-fold gain in very active trading, after pain treatment gets approved in China

Shares of Trevena Inc. TRVN exploded more than five-fold higher — up 420.6% — on very active trading Monday, after the Pennsylvania-based biopharmaceutical company said its China-based partner Jiangsu Nhwa received formal approval from China health regulators for the pain treatment Olinvyk. The stock, which had been halted 21 times for volatility since the open, has seen 75.7 million shares change hands, compared with the full-day average over the past 30 days of about 111,100 shares.

10:34 28 Mar 2024 TRVN

Best Penny Stocks To Buy Now? 4 To Watch Before May CPI Data

Are these the best penny stocks to buy right now? Here's what's moving on Monday.

10:20 28 Mar 2024 TRVN

Why Is Trevena (TRVN) Stock Up 165% Today?

Trevena (NASDAQ: TRVN ) stock is rocketing higher on Monday after Chinese partner Jiangsu Nhwa got approval for one of its treatments. The National Medical Products Administration granted approval to Jiangsu Nhwa for Trevena's OLINVYK.

07:00 28 Mar 2024 TRVN

Trevena to Participate in Three Upcoming Conferences

CHESTERBROOK, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that members of Management will participate in three upcoming conferences.

03:07 28 Mar 2024 TRVN

Trevena, Inc. (TRVN) Q4 2022 Earnings Call Transcript

Trevena, Inc. (NASDAQ:TRVN ) Q4 2022 Earnings Conference Call March 30, 2023 8:00 AM ET Company Participants Barry Shin - Chief Financial Officer Carrie Bourdow - President and Chief Executive Officer Patty Drake - Chief Commercial Officer Mark Demitrack - Chief Medical Officer Conference Call Participants Jason Butler - JMP Securities Brandon Folkes - Cantor Fitzgerald Douglas Tsao - H.C. Wainwright Operator Greetings, and welcome to the Trevena Fourth Quarter and Full Year 2022 Earnings Call.

TRVN Financial details

Company Rating
Neutral
Market Cap
6.98M
Income
-29.37M
Revenue
3.21M
Book val./share
0.25
Cash/share
2.5
Dividend
-
Dividend %
-
Employees
35
Optionable
No
Shortable
Yes
Earnings
07 Nov 2023
P/E
-0.23
Forward P/E
-0.74
PEG
0.03
P/S
4.31
P/B
0.87
P/C
0.19
P/FCF
-0.28
Quick Ratio
3.44
Current Ratio
4.03
Debt / Equity
9.95
LT Debt / Equity
9.67
-
-
EPS (TTM)
-2.66
EPS next Y
-0.64
EPS next Q
-0.53
EPS this Y
-3.19%
EPS next Y
-75.94%
EPS next 5Y
-330.83%
EPS last 5Y
-6.21%
Revenue last 5Y
NAN%
Revenue Q/Q
-94.04%
EPS Q/Q
-17.39%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0.17%
Inst Trans
0%
ROA
-93%
ROE
-253%
ROC
-1.35%
Gross Margin
-9%
Oper. Margin
-1600%
Profit Margin
-1401%
Payout
-
Shs Outstand
15.17M
Shs Float
14.85M
-
-
-
-
Target Price
-
52W Range
0.4068-3.28
52W High
-
52W Low
-
RSI
32
Rel Volume
0.77
Avg Volume
108.34K
Volume
82.94K
Perf Week
-10.36%
Perf Month
-23.33%
Perf Quarter
-16.67%
Perf Half Y
-26.77%
-
-
-
-
Beta
1.91375
-
-
Volatility
0.02%, 0.05%
Prev Close
3.58%
Price
0.475
Change
4.17%

TRVN Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.950.010.60.09-0.06
Net income per share
-10.46-7.65-5.75-7.84-7.59
Operating cash flow per share
-8.62-6.45-4.19-7.69-7.28
Free cash flow per share
-8.68-6.45-4.2-7.69-7.28
Cash per share
20.99.7621.4310.255.42
Book value per share
14.118.220.399.92.21
Tangible book value per share
14.118.220.399.92.21
Share holders equity per share
14.118.220.399.92.21
Interest debt per share
6.673.921.531.092.97
Market cap
31.63M77.12M273.12M95.19M10.11M
Enterprise value
16.13M58.28M171.52M35.37M-8.44M
P/E ratio
-1.03-2.75-9.3-1.86-0.19
Price to sales ratio
5.522.49K88.99167.89-24.19
POCF ratio
-1.25-3.26-12.77-1.9-0.2
PFCF ratio
-1.24-3.26-12.75-1.9-0.2
P/B Ratio
0.762.562.621.470.65
PTB ratio
0.762.562.621.470.65
EV to sales
2.811.88K55.8962.3820.2
Enterprise value over EBITDA
-0.58-2.51-5.82-0.680.15
EV to operating cash flow
-0.64-2.46-8.02-0.70.16
EV to free cash flow
-0.63-2.46-8.01-0.70.16
Earnings yield
-0.97-0.36-0.11-0.54-5.31
Free cash flow yield
-0.81-0.31-0.08-0.53-5.09
Debt to equity
0.420.450.070.111.27
Debt to assets
0.260.290.060.090.41
Net debt to EBITDA
0.560.813.451.150.33
Current ratio
3.554.127.197.74.7
Interest coverage
-13.67-28.55-1.02K-51.93K-44.88
Income quality
0.820.950.730.970.96
Dividend Yield
00000
Payout ratio
0-0.01-0.04-0.010
Sales general and administrative to revenue
3.31426.196.2767.220
Research and developement to revenue
2.76428.744.2823.68-43.57
Intangibles to total assets
00000
Capex to operating cash flow
0.010000
Capex to revenue
-0.030-0.01-0.030.07
Capex to depreciation
-0.260-0.06-0.04-0.07
Stock based compensation to revenue
0.76104.261.077.77-8.79
Graham number
57.6437.5851.3741.7819.41
ROIC
-0.53-0.58-0.25-0.65-1.35
Return on tangible assets
-0.46-0.6-0.23-0.64-1.1
Graham Net
12.315.1518.138.060.8
Working capital
44.6M28.38M102.48M61.54M32.28M
Tangible asset value
41.53M30.08M104.07M64.63M15.6M
Net current asset value
36.84M20.57M95.37M55.23M7.93M
Invested capital
0.420.450.070.111.27
Average receivables
004.54M4.54M0.5
Average payables
1.42M1.23M1.37M3.12M3.46M
Average inventory
000.51.18M1.63M
Days sales outstanding
001.08K00
Days payables outstanding
03.54K3.4K1.74K286.87
Days of inventory on hand
000899.87109.57
Receivables turnover
000.34567K0
Payables turnover
00.10.110.211.27
Inventory turnover
00182K0.413.33
ROE
-0.74-0.93-0.28-0.79-3.44
Capex per share
-0.060-0.0100

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
-0.06000.260.01
Net income per share
-2.17-0.78-0.62-0.69-0.57
Operating cash flow per share
-1.55-1.11-1.13-0.63-0.64
Free cash flow per share
-1.56-1.11-1.13-0.63-0.64
Cash per share
5.913.992.862.432.5
Book value per share
3.21.631.060.840.25
Tangible book value per share
3.21.631.060.840.25
Share holders equity per share
3.21.631.060.840.25
Interest debt per share
32.122.091.832.54
Market cap
26.16M13.72M6.72M10.2M8.42M
Enterprise value
23.8M-4.84M-1.12M2.18M8.78M
P/E ratio
-0.44-0.46-0.28-0.32-0.27
Price to sales ratio
-59.7101.12K3.3846.78
POCF ratio
-2.47-1.29-0.62-1.41-0.94
PFCF ratio
-2.46-1.29-0.62-1.4-0.94
P/B Ratio
1.20.880.661.042.37
PTB ratio
1.20.880.661.042.37
EV to sales
-54.340-187.360.7248.79
Enterprise value over EBITDA
-1.540.520.11-0.35-1.06
EV to operating cash flow
-2.240.450.1-0.3-0.98
EV to free cash flow
-2.240.450.1-0.3-0.98
Earnings yield
-0.57-0.54-0.89-0.79-0.94
Free cash flow yield
-0.41-0.78-1.62-0.71-1.06
Debt to equity
0.921.271.932.059.95
Debt to assets
0.390.410.510.520.78
Net debt to EBITDA
0.151.990.771.29-0.04
Current ratio
4.64.73.844.036.41
Interest coverage
-39.29-17.64-22.69-5.52-42.03
Income quality
0.691.521.390.91.13
Dividend Yield
0.550000
Payout ratio
-0.980000
Sales general and administrative to revenue
00000
Research and developement to revenue
-12.020651.51.3223.67
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
0.0600-0.010
Capex to depreciation
-0.310.340-0.240
Stock based compensation to revenue
-1.740134.330.233.83
Graham number
12.515.333.853.631.8
ROIC
-0.32-0.24-0.22-0.18-0.2
Return on tangible assets
-0.29-0.15-0.16-0.21-0.18
Graham Net
1.70.59-0.03-0.05-0.43
Working capital
33.28M32.28M22.75M24.79M33.32M
Tangible asset value
21.86M15.6M10.15M9.78M3.55M
Net current asset value
13.38M7.93M2.63M3.89M-2.11M
Invested capital
0.921.271.932.059.95
Average receivables
0.50.50.5189.5K
Average payables
2.07M1.89M2.02M2.1M2.04M
Average inventory
1.89M845.5K906K903.5K900.5K
Days sales outstanding
000.02089.5
Days payables outstanding
53.82936.321.18K2.58K794.57
Days of inventory on hand
29.84357.63642.05921.48462.86
Receivables turnover
-438K06K3.02M1.01
Payables turnover
1.670.10.080.030.11
Inventory turnover
3.020.250.140.10.19
ROE
-0.68-0.48-0.59-0.82-2.23
Capex per share
00000

TRVN Frequently Asked Questions

What is Trevena, Inc. stock symbol ?

Trevena, Inc. is a US stock , located in Chesterbrook of Pa and trading under the symbol TRVN

What is Trevena, Inc. stock quote today ?

Trevena, Inc. stock price is $0.475 today.

Is Trevena, Inc. stock public?

Yes, Trevena, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated Stocks
Similar Market Cap